María del Carmen Rial

Conversion From Calcineurin Inhibitors to Sirolimus Maintenance Therapy in Renal Allograft Recipients: 24-Month Efficacy and Safety Results From the CONVERT Trial

Francesco Paolo Schena, M.D. Pascoe, Josefina Alberú et al. · Transplantation · 2009 · 576 citations

Pharmacy, Nephrology, Pharmacotherapy +17

Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplants from Extended Criteria Donors (BENEFIT‐EXT Study)

Antoine Dürrbach, JO Medina Pestana, Thomas C. Pearson et al. · American Journal of Transplantation · 2010 · 565 citations · Full text

Medicine, Nephrology, Pharmacotherapy +17

Three-Year Outcomes From BENEFIT-EXT: A Phase III Study of Belatacept Versus Cyclosporine in Recipients of Extended Criteria Donor Kidneys

José Osmar Medina Pestana, J.M. Grinyó, Yves Vanrenterghem et al. · American Journal of Transplantation · 2012 · 262 citations · Full text

Medicine, Nephrology, Pharmacotherapy +12

Lower Malignancy Rates in Renal Allograft Recipients Converted to Sirolimus-Based, Calcineurin Inhibitor-Free Immunotherapy: 24-Month Results From the CONVERT Trial

Josefina Alberú, M.D. Pascoe, Josep M. Campistol et al. · Transplantation · 2011 · 222 citations

Medicine, Immunology, Nephrology +17

Switching from Calcineurin Inhibitor-based Regimens to a Belatacept-based Regimen in Renal Transplant Recipients

Lionel Rostaing, P. Massari, Valter Duro Garcı́a et al. · Clinical Journal of the American Society of Nephrology · 2010 · 185 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13